Oncology Central

NCRI 2018: Fluorescent marker helps improve accuracy of brain tumor cell removal

Researchers have found a new fluorescent biomarker that has the ability to distinguish high-grade glioma tissue from low-grade and normal brain tissue. This ability allows for the real time intra-operative differentiation of cell types during surgical procedures, resulting in a more accurate and complete removal of the tumor that can help improve outcomes.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.